Ionis Pharmaceuticals Inc. Stock
Ionis Pharmaceuticals Inc. gained 0.920% compared to yesterday.
The stock is one of the favorites of our community with 63 Buy predictions and 1 Sell predictions.
With a target price of 79 € there is a hugely positive potential of 63.93% for Ionis Pharmaceuticals Inc. compared to the current price of 48.19 €.
Our community identified positive and negative aspects for Ionis Pharmaceuticals Inc. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Ionis Pharmaceuticals Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Ionis Pharmaceuticals Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ionis Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ionis Pharmaceuticals Inc. | 0.920% | -1.709% | -33.217% | 27.096% | -29.738% | 32.308% | 49.546% |
| Ligand Pharmaceuticals | 0.760% | 0.769% | -6.429% | 127.826% | 57.831% | 329.508% | 184.103% |
| United Therapeutics | -3.270% | -2.132% | -7.599% | 77.826% | 5.289% | 109.646% | 158.563% |
| Novocure Ltd | 0.600% | -1.570% | -6.186% | 38.692% | 24.438% | -45.604% | -89.095% |
Comments
Ionis Pharmaceuticals (IONS) had its price target raised by JPMorgan Chase & Co. from $72.00 to $76.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its price target lowered by Wells Fargo & Company from $100.00 to $95.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat
Ionis Pharmaceuticals (IONS) had its price target lowered by HC Wainwright from $125.00 to $115.00. They now have a "buy" rating on the stock.
Show more
Ratings data for IONS provided by MarketBeat